Lee Sejin, Song Jeong Ho, Park Sung Hyun, Cho Minah, Kim Yoo Min, Kim Hyoung-Il, Hyung Woo Jin
Department of Surgery, Jeonbuk National University Hospital, Jeonju 54907, Korea.
Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Korea.
Cancers (Basel). 2021 Nov 17;13(22):5768. doi: 10.3390/cancers13225768.
Additional surgery after non-curative endoscopic submucosal dissection (ESD) may be excessive as few patients have lymph node metastasis (LNM). It is necessary to develop a risk stratification system for LNM after non-curative ESD, such as the eCura system, which was introduced in the Japanese gastric cancer treatment guidelines. However, the eCura system requires venous and lymphatic invasion to be separately assessed, which is difficult to distinguish without special immunostaining. In this study, we practically modified the eCura system by classifying lymphatic and venous invasion as lymphovascular invasion (LVI).
We retrospectively reviewed 543 gastric cancer patients who underwent radical gastrectomy after non-curative ESD between 2006 and 2019. LNM was evaluated according to LVI as well as size >30 mm, submucosal invasion ≥500 µm, and vertical margin involvement, which were used in the eCura system.
LNM was present in 8.1% of patients; 3.6%, 2.3%, 7.4%, 18.3%, and 61.5% of patients with no, one, two, three, and four risk factors had LNM, respectively. The LNM rate in the patients with no risk factors (3.6%) was not significantly different from that in patients with one risk factor (2.3%, = 0.523). Among patients with two risk factors, the LNM rate without LVI was significantly lower than with LVI (2.4% vs. 10.7%, = 0.027). Among patients with three risk factors, the LNM rate without LVI was lower than with LVI (0% vs. 20.8%, = 0.195), although not statistically significantly. Based on LNM rates according to risk factors, patients with LVI and other factors were assigned to the high-risk group (LNM, 17.4%) while other patients as a low-risk group (LNM, 2.4%).
Modifying the eCura system by classifying lymphatic and venous invasion as LVI successfully stratified LNM risk after non-curative ESD. Moreover, the high-risk group can be simply identified based on LVI and the presence of other risk factors.
在非根治性内镜黏膜下剥离术(ESD)后进行额外手术可能过度,因为很少有患者发生淋巴结转移(LNM)。有必要开发一种非根治性ESD后LNM的风险分层系统,如日本胃癌治疗指南中引入的eCura系统。然而,eCura系统要求分别评估静脉和淋巴管侵犯,若无特殊免疫染色则难以区分。在本研究中,我们通过将淋巴管和静脉侵犯归类为脉管侵犯(LVI)对eCura系统进行了实际改良。
我们回顾性分析了2006年至2019年间543例行非根治性ESD后接受根治性胃切除术的胃癌患者。根据LVI以及eCura系统中使用的肿瘤大小>30mm、黏膜下浸润≥500μm和切缘受累情况评估LNM。
8.1%的患者发生LNM;无、一、二、三、四个危险因素的患者发生LNM的比例分别为3.6%、2.3%、7.4%、18.3%和61.5%。无危险因素患者的LNM发生率(3.6%)与有一个危险因素患者的LNM发生率(2.3%,P = 0.523)无显著差异。在有两个危险因素的患者中,无LVI患者的LNM发生率显著低于有LVI患者(2.4%对10.7%,P = 0.027)。在有三个危险因素的患者中,无LVI患者的LNM发生率低于有LVI患者(0%对20.8%,P = 0.195),尽管差异无统计学意义。根据危险因素的LNM发生率,有LVI及其他因素的患者被归为高危组(LNM,17.4%),而其他患者为低危组(LNM,2.4%)。
通过将淋巴管和静脉侵犯归类为LVI对eCura系统进行改良,成功地对非根治性ESD后的LNM风险进行了分层。此外,基于LVI和其他危险因素的存在可简单识别高危组。